**Multiple IPOs have priced or are scheduled for late September and early October 2026, including Roze AI, Oura, and Accelevation Holdings, with additional filings and SPAC activity continuing.** The U.S. IPO market has already seen 249 listings year-to-date through September 29, raising substantial proceeds amid a Nasdaq Composite advance of roughly 35% for the year. Strong demand for AI, biotech, and health-tech names, combined with supportive equity valuations and a pipeline of S-1 filings, has sustained momentum despite selective pullbacks and market volatility concerns. Key near-term catalysts include several priced offerings in the final days of September and ongoing SEC registrations that could accelerate into Q4, reinforcing the likelihood of further listings before year-end.